Synthetic lethality--a new direction in cancer-drug development
- PMID: 19553640
- DOI: 10.1056/NEJMe0903044
Synthetic lethality--a new direction in cancer-drug development
Comment on
-
Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.N Engl J Med. 2009 Jul 9;361(2):123-34. doi: 10.1056/NEJMoa0900212. Epub 2009 Jun 24. N Engl J Med. 2009. PMID: 19553641 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical